EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY-NC 4.0

First‐trimester biomarkers of gestational diabetes mellitus: A scoping review

May Swinburne iD, Samuel Krasner iD, Sam Mathewlynn, Sally Collins

Acta Obstetricia et Gynecologica Scandinavica · 2025-10 · 104 (10) · 1838-1848

DOI: 10.1111/aogs.70046 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Acta Obstetricia et Gynecologica Scandinavica, online erschienen am 29.08.2025. Verfasst von May Swinburne und 3 weiteren Autor:innen. Beteiligte Einrichtung: Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK. Hauptthemen laut MEDLINE: Diabetes, Gestational, Pregnancy Trimester, First. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gestational diabetes mellitus (GDM) affects approximately 14% of pregnancies globally, with rising incidence depending on the diagnostic criteria used. In the UK, screening relies on risk factors at booking, followed by a diagnosis via an oral glucose tolerance test in the second trimester. This approach may lack sensitivity and has poor tolerability. Emerging evidence suggests that GDM pathophysiology begins in the first trimester, with biomarkers showing potential for early prediction. Identifying these could enable earlier risk stratification, improved diagnostic pathways, and better maternal–fetal outcomes. This scoping review maps the existing literature on first‐trimester biomarkers of GDM to evaluate their clinical utility and integration into predictive models. A literature search was conducted using Medline, Embase, and PubMed to identify studies on first‐trimester biomarkers of GDM. Inclusion criteria included (1) studies investigating biomarkers at

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes, GestationalPregnancy Trimester, FirstHumansPregnancyFemaleBiomarkersGlucose Tolerance Test

Stichwörter der Autor:innen

first biomarkers PAPP‐A (pregnancy‐associated plasma protein‐a) PlGF (placental…gestational diabetes mellitus pregnancy trimester

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK.
  • Cardiovascular Clinical Research Facility, Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
  • Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Birmingham Women and Children's NHS Foundation Trust, Birmingham, UK.

ORCID-Profile: May Swinburne, Samuel Krasner

Zitieren

APA

Swinburne, M., Krasner, S., Mathewlynn, S., & Collins, S. (2025). First‐trimester biomarkers of gestational diabetes mellitus: A scoping review. Acta Obstetricia et Gynecologica Scandinavica, 104(10), 1838-1848. https://doi.org/10.1111/aogs.70046

Vancouver

Swinburne M, Krasner S, Mathewlynn S, Collins S. First‐trimester biomarkers of gestational diabetes mellitus: A scoping review. Acta Obstetricia et Gynecologica Scandinavica. 2025;104(10):1838-1848. doi:10.1111/aogs.70046

BibTeX
@article{Swinburne2025,
  author = {Swinburne, May and Krasner, Samuel and Mathewlynn, Sam and Collins, Sally},
  title = {First‐trimester biomarkers of gestational diabetes mellitus: A scoping review},
  journal = {Acta Obstetricia et Gynecologica Scandinavica},
  year = {2025},
  volume = {104},
  number = {10},
  pages = {1838--1848},
  doi = {10.1111/aogs.70046}
}
Kostenlos starten →